Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Amphastar Pharmaceuticals Inc. (AMPH) Q1 2025 Earnings Call Transcript
07:20pm, Wednesday, 07'th May 2025
Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications William Peter
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates
06:41pm, Wednesday, 07'th May 2025
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.04 per share a year ago.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
04:05pm, Wednesday, 07'th May 2025
Reports Net Revenues of $170.5 Million for the Three Months Ended March 31, 2025 RANCHO CUCAMONGA, CA / ACCESS Newswire / May 7, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or th
Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock?
04:10pm, Thursday, 01'st May 2025
Investors need to pay close attention to Amphastar (AMPH) stock based on the movements in the options market lately.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025
06:00am, Wednesday, 30'th Apr 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2025 ended March 31, 20
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
06:00am, Thursday, 03'rd Apr 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 3, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be parti
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
06:00am, Friday, 28'th Mar 2025
Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) to
New Strong Sell Stocks for March 24th
06:30am, Monday, 24'th Mar 2025
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
06:00am, Wednesday, 05'th Mar 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Oper
Amphastar Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - AMPH
07:30am, Tuesday, 04'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Amphastar Pharmaceuticals, Inc. ("Amphastar Pharmaceuticals, Inc.") (NASD
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Amphastar Pharmaceuticals, Inc. ("Amphastar Pharmaceuticals, Inc.") (NASD
Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds
02:15pm, Friday, 28'th Feb 2025
On Thursday, Amphastar Pharmaceuticals Inc. AMPH reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents.
Amphastar: Earnings Miss, Margins Drop
09:56am, Friday, 28'th Feb 2025
Amphastar Pharmaceuticals posted modest earnings growth but fell short of market expectations in its latest quarterly results.
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Amphastar Pharmaceuticals, Inc. ("Amphastar Pharmaceuticals, Inc.") (
Amphastar Pharmaceuticals Inc. (AMPH) Q4 2024 Earnings Call Transcript
11:04pm, Thursday, 27'th Feb 2025
Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications Willia
